Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracycline Pleurodesis for PSP Recurrence Prevention
NCT03634605Completed
- Start
- May 2015
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tetracycline in primary spontaneous pneumothorax (PSP) (2 arms). Primary endpoint: Recurrence of Primary Spontaneous Pneumothorax at 12 months. Started May 2015; status: completed.
02
Drugs
tetracycline
03
Conditions
primary spontaneous pneumothorax (PSP)
Beyond the preview
Go deeper on NCT03634605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03634605.